Pharvaris N.V.
PHVS
$28.16
$4.0416.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.75% | 3.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.20% | 3.21% | |||
| Operating Income | -1.20% | -3.21% | |||
| Income Before Tax | 15.10% | -6.07% | |||
| Income Tax Expenses | -192.22% | -27.76% | |||
| Earnings from Continuing Operations | 15.89% | -5.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.89% | -5.85% | |||
| EBIT | -1.20% | -3.21% | |||
| EBITDA | -1.20% | -3.20% | |||
| EPS Basic | 26.11% | -5.45% | |||
| Normalized Basic EPS | 25.42% | -5.69% | |||
| EPS Diluted | 26.11% | -5.45% | |||
| Normalized Diluted EPS | 25.42% | -5.69% | |||
| Average Basic Shares Outstanding | 13.84% | 0.37% | |||
| Average Diluted Shares Outstanding | 13.84% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||